Cover Image
市場調查報告書

全球創傷護理用生物製劑市場:企業簡介,規模,佔有率,成長率,趨勢,預測

Global Wound Care Biologics Market: Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

出版商 Data Bridge Market Research Private Limited 商品編碼 695340
出版日期 內容資訊 英文 397 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球創傷護理用生物製劑市場:企業簡介,規模,佔有率,成長率,趨勢,預測 Global Wound Care Biologics Market: Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025
出版日期: 2018年08月01日 內容資訊: 英文 397 Pages
簡介

本報告提供全球創傷護理用生物製劑市場相關調查分析,市場概要,各市場區隔的市場分析,各地區的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 市場區隔

第3章 市場概要

  • 促進因素
  • 阻礙因素
  • 機會
  • 課題

第4章 摘要整理

第5章 重要考察

第6章 全球創傷護理用生物製劑市場:各類型產品

  • 概要
  • 人工合成皮膚移植片
  • 細胞生長因子
  • 異體移植片
  • 異質骨移植

第7章 全球創傷護理用生物製劑市場:創傷的各類型

  • 概要
  • 創傷
  • 燙傷

第8章 全球創傷護理用生物製劑市場:各終端用戶

  • 概要
  • 醫院
  • 創傷護理中心
  • ASC
  • 診所
  • 地區醫療中心

第9章 全球創傷護理用生物製劑市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第10章 全球創傷護理用生物製劑市場:企業形勢

  • 企業佔有率分析:全球
  • 企業佔有率分析:北美
  • 企業佔有率分析:歐洲
  • 企業佔有率分析:亞太地區

第11章 企業簡介

  • MIMEDX
  • ORGANOGENESIS INC.
  • INTEGRA LIFESCIENCES
  • CONVATEC INC.
  • ACELL INC.
  • ALLOSOURCE
  • ALPHATEC SPINE, INC.
  • AMNIO TECHNOLOGY, LLC
  • AMNIOX MEDICAL, INC.
  • ANIKA THERAPEUTICS, INC.
  • BIOHORIZONS IPH, INC.
  • KERECIS
  • MARINE POLYMER TECHNOLOGIES, INC.
  • MOLNLYCKE HEALTH CARE AB
  • OSIRIS THERAPEUTICS, INC.
  • SKYE BIOLOGICS INC.
  • SMITH AND NEPHEW
  • SOLSYS MEDICAL
  • VERICEL CORPORATION
  • WRIGHT MEDICAL GROUP N.V

第12章 相關調查

目錄

Global wound care biologics market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases aging population, innovation in wound care biologics are fuel the growth of wound care biologics market.

The key market players for global wound care biologics s market are listed below:

  • Smith and Nephew
  • INTEGRA LIFE SCIENCES CORPORATION
  • Molnlycke Health Care AB
  • Amnio Technology, LLC
  • Alphatec Spine, Inc.
  • BioHorizons IPH, Inc.
  • ORGANOGENESIS INC
  • CONVATEC AG
  • Skye Biologics Inc.
  • Anika Therapeutics, Inc.
  • Osiris Therapeutics, Inc.
  • Vericel Corporation
  • MiMedx
  • WRIGHT MEDICAL GROUP N.V.
  • Kerecis
  • ACell Inc.
  • Solsys Medical
  • Marine Polymer Technologies, Inc.
  • Amniox Medical, Inc.
  • Amniox Medical, Inc.

The global wound care biologics market is segmented into:

  • Product Type
  • Wound Type
  • End User

On the basis of product type the global wound care biologics market is segmented into synthetic skin grafts, growth factors, allografts, xenografts. In 2018, synthetic skin grafts segment is expected to dominate the Global wound care biologics market with highest market shares. However, allografts segment is expected to grow at the highest CAGR in the forecast period. Growth factors segment is further sub segmented into platelet-derived growth factor (PDGF)segment, platelet rich plasma (PRP)segment, epidermal growth factor (EGF)segment and basic fibroblast growth factor (BFGF)segment, granulocyte colony stimulating factor (G-CSF) segment, talactoferrin alfa, thrombin peptide (TP508)segment, keratinocyte growth factor (KGF)segment.

On the basis of wound type the global wound care biologics market is categorized into wounds, and ulcers, burns. In 2018, wounds segmentis expected to dominate the global wound care biologics market with the highest market shares. However, ulcers segment is expected to grow at the highest CAGR in the forecast period.

On the basis of end user the global wound care biologics s market is segmented into hospitals, wound care centres and ambulatory centers, clinics, community healthcare centers. In 2018, hospitals are expected to dominate the global wound care biologics market with the highest market shares in the forecast period 2018 to 2025.

Based on geography, the market is segmented into 5 geographical regions:

  • Europe
  • North America
  • Asia-Pacific
  • South America
  • Middle East & Africa

Covered in this report

The report covers the present scenario and the growth prospects of the global wound care biologics market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

TABLE OF CONTENTS

Table Of Contents

1 Introduction 31

  • 1.1 Objectives Of The Study 31
  • 1.2 Market Definition 31
  • 1.3 Overview Of Global Wound Care Biologics Market 31
  • 1.4 Currency And Pricing 32
  • 1.5 Limitation 32
  • 1.6 Markets Covered 33

2 Market Segmentation 35

  • 2.1 Markets Covered 35
  • 2.2 Geographic Scope 36
  • 2.3 Years Considered For The Study 37
  • 2.4 Currency And Pricing 37
  • 2.5 Research Methodology 38
  • 2.6 Primary Interviews With Key Opinion Leaders 41
  • 2.1 Dbmr Market Position Grid 42
  • 2.2 Dbmr Market Challenge Matrix 43
  • 2.3 Secondary Sources 44
  • 2.4 Assumptions 44

3 Market Overview 45

  • 3.1 Drivers 47
    • 3.1.1 Increasing Cases Of Diabetic Foot Ulcers 47
    • 3.1.2 Increasing Incidences Of Burn Cases 47
    • 3.1.3 Rising Number Of Geriatric Population 48
    • 3.1.4 Innovation In Wound Care Biologics 49
    • 3.1.5 New Product Launches 51
  • 3.2 Restrains 51
    • 3.2.1 High Cost Of Wound Treatment And Wound Care Biologics 51
    • 3.2.2 Risk Of Skin Substitue Failure 52
  • 3.3 Opportunities 53
    • 3.3.1 3D Skin Printing 53
    • 3.3.2 Awareness Programs 54
  • 3.4 Challenges 55
    • 3.4.1 Lack Of Wound Management Services 55

4 Executive Summary 56

5 Premium Insights 60

6 Global Wound Care Biologics Market, By Product Type 65

  • 6.1 Overview 66
  • 6.2 Synthetic Skin Grafts 68
  • 6.3 Growth Factors 69
    • 6.3.1 Platelet Derived Growth Factor (Pdgf) 72
    • 6.3.2 Platelet Rich Plasma (Prp) 72
    • 6.3.3 Epidermal Growth Factors (Egf) 72
    • 6.3.4 Basic Fibroblast Growth Factors (Bfgf) 73
    • 6.3.5 Granulocyte Colony Stimulating Factor (G-Csf) 73
    • 6.3.6 Talactoferrin Alfa 73
    • 6.3.7 Thrombin Peptide 74
    • 6.3.8 Keratinocy Growth Factor (Kgf) 74
  • 6.4 Allografts 75
  • 6.5 Xenografts 76

7 Global Wound Care Biologics Market, By Wound Type 78

  • 7.1 Overview 79
  • 7.2 Wounds 80
    • 7.2.1 Surgical Wound 82
      • 7.2.1.1 Skin Surgery 83
        • 7.2.1.1.1 Wound Closure 84
        • 7.2.1.1.2 Skin Biopsy 84
        • 7.2.1.1.3 Skin Flap 84
        • 7.2.1.1.4 Skin Graft 84
        • 7.2.1.1.5 Others 84
      • 7.2.1.2 Cosmetic Procedure 85
        • 7.2.1.2.1 Brest Enhancement 86
        • 7.2.1.2.2 Facial Contouring 87
        • 7.2.1.2.3 Facial Rejuvenation: 87
        • 7.2.1.2.4 Body Contouring 87
        • 7.2.1.2.5 Skin Rejuvenation 87
        • 7.2.1.2.6 Others 88
      • 7.2.1.3 Gynecologic Procedures 88
        • 7.2.1.3.1 Pubovaginalis Sling 88
        • 7.2.1.3.2 Pelvic Floor Reconstruction 89
        • 7.2.1.3.3 Rectocele Repair Surgery 89
        • 7.2.1.3.4 Others 89
      • 7.2.1.4 Gastrointestinal Procedure 89
        • 7.2.1.4.1 General Gastrointestinal Surgery 90
        • 7.2.1.4.2 Hernia 91
        • 7.2.1.4.3 Others 91
    • 7.2.2 Acute Wounds 92
    • 7.2.3 Chronic Wounds 92
    • 7.2.4 Traumatic Wounds 93
  • 7.3 Burns 93
    • 7.3.1 Ulcers 94
    • 7.3.2 Diabetic Ulcers 96
    • 7.3.3 Pressure Ulcer 96
    • 7.3.4 Venous Ulcer 97
    • 7.3.5 Others 97

8 Global Wound Care Biologics Market, By End User 98

  • 8.1 Overview 99
  • 8.2 Hospitals 101
  • 8.3 Wound Care Centers 102
  • 8.4 Ambulatory Surgical Centers 103
  • 8.5 Clinics 105
  • 8.6 Community Healthcare Center 106

9 Global Wound Care Biologics Market: Geography 107

  • 9.1 Global 107
  • 9.2 North America 114
    • 9.2.1 U.S. 125
    • 9.2.2 Canada 132
    • 9.2.3 Mexico 139
  • 9.3 Europe 146
    • 9.3.1 Germany 158
    • 9.3.2 France 165
    • 9.3.3 U.K. 172
    • 9.3.4 Italy 179
    • 9.3.5 Switzerland 186
    • 9.3.6 Netherlands 193
    • 9.3.7 Russia 201
    • 9.3.8 Turkey 208
    • 9.3.9 Spain 215
    • 9.3.10 Belgium 222
    • 9.3.11 Rest Of Europe 229
  • 9.4 Asia-Pacific 230
    • 9.4.1 China 242
    • 9.4.2 Japan 249
    • 9.4.3 India 256
    • 9.4.4 South Korea 263
    • 9.4.5 Australia 270
    • 9.4.6 Thailand 277
    • 9.4.7 Malaysia 284
    • 9.4.8 Singapore 291
    • 9.4.9 Indonesia 298
    • 9.4.10 Philippines 305
    • 9.4.11 Rest Of Asia-Pacific 312
  • 9.5 South America 313
    • 9.5.1 Brazil 324
    • 9.5.2 Rest Of South America 331
  • 9.6 Middle East & Africa 332
    • 9.6.1 South Africa 343
    • 9.6.2 Rest Of Middle East & Africa 350

10 Global Wound Care Biologics Market, Company Landscape 351

  • 10.1 Company Share Analysis: Global 351
  • 10.2 Company Share Analysis: North America 352
  • 10.3 Company Share Analysis: Europe 353
  • 10.4 Company Share Analysis: Asia-Pacific 354

11 Company Profile 355

  • 11.1 Mimedx. 355
    • 11.1.1 Company Overview 355
    • 11.1.2 Revenue Analysis: 355
    • 11.1.3 Company Share Analysis: 356
    • 11.1.4 Product Portfolio 356
    • 11.1.5 Recent Developments 357
  • 11.2 Organogenesis Inc 358
    • 11.2.1 Company Overview 358
    • 11.2.2 Geographic Presence 358
    • 11.2.3 Company Share Analysis: 359
    • 11.2.4 Product Portfolio 359
    • 11.2.5 Recent Developments 360
  • 11.3 Integra Lifesciences 361
    • 11.3.1 Company Overview 361
    • 11.3.2 Revenue Analysis 361
    • 11.3.3 Company Share Analysis: 362
    • 11.3.4 Product Portfolio 362
    • 11.3.5 Recent Developments 363
  • 11.4 Convatec Inc. 364
    • 11.4.1 Company Overview 364
    • 11.4.2 Revenue Analysis 364
    • 11.4.3 Company Share Analysis: 365
    • 11.4.4 Product Portfolio : 365
    • 11.4.5 Recent Developments 365
  • 11.5 Acell Inc. 366
    • 11.5.1 Company Overview 366
    • 11.5.2 Product Portfolio 366
    • 11.5.3 Recent Developments 367
  • 11.6 Allosource 368
    • 11.6.1 Company Overview 368
    • 11.6.2 Product Portfolio 368
    • 11.6.3 Recent Developments 369
  • 11.7 Alphatec Spine, Inc. ( A Subsidary Of Alphatec Holdings, Inc) 370
    • 11.7.1 Company Overview 370
    • 11.7.2 Product Portfolio 370
    • 11.7.3 Recent Developments 370
  • 11.8 Amnio Technology, Llc 371
    • 11.8.1 Company Overview 371
    • 11.8.2 Product Portfolio 371
    • 11.8.3 Recent Developments 372
  • 11.9 Amniox Medical, Inc. 373
    • 11.9.1 Company Overview 373
    • 11.9.2 Product Portfolio 373
    • 11.9.3 Recent Developments 374
  • 11.10 Anika Therapeutics, Inc. 375
    • 11.10.1 Company Overview 375
    • 11.10.2 Revenue Analysis 375
    • 11.10.3 Product Portfolio 376
    • 11.10.4 Recent Developments 376
  • 11.11 Biohorizons Iph, Inc ( A Subsidary Of Henry Schein, Inc.) 377
    • 11.11.1 Company Overview 377
    • 11.11.2 Geographicpresence 377
    • 11.11.3 Product Portfolio 378
    • 11.11.4 Recent Developments 378
  • 11.12 Kerecis 379
    • 11.12.1 Company Overview 379
    • 11.12.2 Geographical Presence 379
    • 11.12.3 Product Portfolio 380
    • 11.12.4 Recent Developments 380
  • 11.13 Marine Polymer Technologies, Inc 381
    • 11.13.1 Company Overview 381
    • 11.13.2 Product Portfolio 381
    • 11.13.3 Recent Developments 381
  • 11.14 Molnlycke Health Care Ab 382
    • 11.14.1 Company Overview 382
    • 11.14.2 Revenue Analysis 382
    • 11.14.3 Product Portfolio 383
    • 11.14.4 Recent Developments 383
  • 11.15 Osiris Therapeutics, Inc. 384
    • 11.15.1 Company Overview 384
    • 11.15.2 Revenue Analysis 384
    • 11.15.3 Product Portfolio 385
    • 11.15.4 Recent Developments 385
  • 11.16 Skye Biologics Inc. 386
    • 11.16.1 Company Overview 386
    • 11.16.2 Product Portfolio : 386
    • 11.16.3 Recent Development: 387
  • 11.17 Smith And Nephew 388
    • 11.17.1 Company Overview 388
    • 11.17.2 Revenue Analysis 388
    • 11.17.3 Product Portfolio 389
    • 11.17.4 Recent Developments 389
  • 11.18 Solsys Medical. 390
    • 11.18.1 Company Overview 390
    • 11.18.2 Product Portfolio 391
    • 11.18.3 Recent Developments 391
  • 11.19 Vericel Corporation. 392
    • 11.19.1 Company Overview 392
    • 11.19.2 1.1.2 Revenue Analysis 392
    • 11.19.3 Product Portfolio 393
    • 11.19.4 Recent Developments 393
  • 11.20 Wright Medical Group N.V 394
    • 11.20.1 Company Overview 394
    • 11.20.2 1.1.2 Revenue Analysis 394
    • 11.20.3 Product Portfolio 395
    • 11.20.4 Recent Developments 396

12 Related Reports 397

LIST OF TABLES

  • Too Lengthy To Be Pasted

LIST OF FIGURES

  • Figure 1 Global Wound Care Biologics Market: Segmentation 35
  • Figure 2 Global Wound Care Biologics Market: Data Triangulation 38
  • Figure 3 Global Wound Care Biologics Market: Research Snapshot 39
  • Figure 4 Global Wound Care Biologics Market: Bottom Up Approach 40
  • Figure 5 Global Wound Care Biologics Market: Top Down Approach 40
  • Figure 6 Global Wound Care Biologics Market: Interview Demographics 41
  • Figure 1 Global Wound Care Biologics Market: Dbmr Market Position Grid 42
  • Figure 2 Global Wound Care Biologics Market: The Market Challenge Matrix 43
  • Figure 3 Drivers, Restraints, Opportunities And Challenges Of Global Wound Care Biologics Market 46
  • Figure 4 Aging Population In Different Countries (2014, 2017 & 2020) 49
  • Figure 5 Global Wound Care Biologics Market: Segmentation 58
  • Figure 6 North America Is Anticipated To Dominate The Global Wound Care Biologics Market And Asia Pacific Is Estimated To Be Increasing With The Strong Cagr In The Forecast Period From 2018 To 2025 59
  • Figure 7 Increasing Prevelance Of Diabetic Foot Ulcers And Increasing Incidences Of Burn Cases Are Expected To Drive The Market For Global Wound Care Biologics In The Forecast Period 2018 To 2025 60
  • Figure 8 Synthetic Skin Grafts In Global Wound Care Biologics Is Expected To Account For The Largest Share Of The Global Wound Care Biologics Market In 2018 & 2025 61
  • Figure 9 Asia Pacific Is The Maximum Growing And Most Profitable Revenue Pockets For Global Wound Care Biologics Market In The Forecast Period From 2018 To 2025 62
  • Figure 10 Worldwide Prevalence Of Various Wound Types, 2011 63
  • Figure 11 Cases Of Burn Injuries, (2009 - 2012) 63
  • Figure 12 Prevalence Of Pressure Ulcers In Few Countries 64
  • Figure 13 Number Of Surgical Procedures And Surgical Site Infections 64
  • Figure 14 Global Wound Care Biologics Market: By Product Type, 2017 66
  • Figure 15 Global Wound Care Biologics Market: By Wound Type, 2017 79
  • Figure 16 Global Wound Care Biologics Market: By End User, Snapshot 2017 99
  • Figure 17 Global Wound Care Biologics Market: Snapshot (2017) 108
  • Figure 18 Global Wound Care Biologics Market: By Country (2017) 109
  • Figure 19 Global Wound Care Biologics Market: By Country (2018 & 2025) 110
  • Figure 20 Global Wound Care Biologics Market, By Country (2017 & 2025) 111
  • Figure 21 Global Wound Care Biologics Market, By Product Type (2018 -2025) 112
  • Figure 22 North America Wound Care Biologics Market: Snapshot (2017) 114
  • Figure 23 North America Wound Care Biologics Market: By Country (2017) 115
  • Figure 24 North America Wound Care Biologics Market: By Country (2018 & 2025) 115
  • Figure 25 North America Wound Care Biologics Market, By Country (2017 & 2025) 116
  • Figure 26 North America Wound Care Biologics Market, By Product Type (2018 -2025) 117
  • Figure 27 Europe Wound Care Biologics Market: Snapshot (2017) 146
  • Figure 28 Europe Wound Care Biologics Market: By Country (2017) 147
  • Figure 29 Europe Wound Care Biologics Market: By Country (2018 & 2025) 148
  • Figure 30 Europe Wound Care Biologics Market, By Country (2017 & 2025) 149
  • Figure 31 Europe Wound Care Biologics Market, By Product Type (2018 -2025) 150
  • Figure 32 Asia-Pacific Wound Care Biologics Market: Snapshot (2017) 230
  • Figure 33 Asia-Pacific Wound Care Biologics Market: By Country (2017) 231
  • Figure 34 Asia-Pacific Wound Care Biologics Market: By Country (2018 & 2025) 232
  • Figure 35 Asia-Pacific Wound Care Biologics Market, By Country (2017 & 2025) 233
  • Figure 36 Asia-Pacific Wound Care Biologics Market, By Product Type (2018 -2025) 234
  • Figure 37 South America Wound Care Biologics Market: Snapshot (2017) 313
  • Figure 38 South America Wound Care Biologics Market: By Country (2017) 314
  • Figure 39 South America Wound Care Biologics Market: By Country (2018 & 2025) 314
  • Figure 40 South America Wound Care Biologics Market, By Country (2017 & 2025) 315
  • Figure 41 South America Wound Care Biologics Market, By Product Type (2018 -2025) 316
  • Figure 42 Middle East & Africa Wound Care Biologics Market: Snapshot (2017) 332
  • Figure 43 Middle East & Africa Wound Care Biologics Market: By Country (2017) 333
  • Figure 44 Middle East & Africa Wound Care Biologics Market: By Country (2018 & 2025) 333
  • Figure 45 Middle East & Africa Wound Care Biologics Market, By Country (2017 & 2025) 334
  • Figure 46 Middle East & Africa Wound Care Biologics Market, By Product Type (2018 -2025) 335
  • Figure 47 Global Wound Care Biologics Market: Company Share 2017 (%) 351
  • Figure 48 North America Wound Care Biologics Market: Company Share 2017 (%) 352
  • Figure 49 Europe Wound Care Biologics Market: Company Share 2017 (%) 353
  • Figure 50 Asia-Pacific Wound Care Biologics Market: Company Share 2017 (%) 354
Back to Top